News

Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.

North Bergen, New Jersey--(Newsfile Corp. - February 10, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company) is pleased to…

51 minutes ago

PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExplore™ for Standardized Histopathology Endpoints

BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, today announced the strategic expansion of…

2 hours ago

Codexis Achieves ISO 9001:2015 Certification

REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for…

2 hours ago

Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

The new partnership combines Weight Watchers’ scientifically-backed medical and behavioral expertise with PVOLVE’s clinically-studied method to support members at every…

2 hours ago

Imprivata Introduces Advanced Access Management and Passwordless Authentication Capabilities to Improve User Efficiency and Strengthen Security

Tailored for all users and workflows, Imprivata Enterprise Access Management now offers context-aware passwordless authentication, advanced biometrics, and AI-powered behavioral…

2 hours ago

Practicing Excellence Acquires Sageful AI to Accelerate Scalable Behavior Change Across Healthcare

Combined organization strengthens personalized, in-workflow coaching aligned to organizational prioritiesSAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Practicing Excellence, the…

2 hours ago

NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence

LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of…

2 hours ago

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful…

2 hours ago

Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline

WHO recognition of “etaroleucel” (CELZ-101) builds on prior “olastrocel” (CELZ-201) milestone, reinforcing platform credibility and supporting multi-program executionPHOENIX, Feb. 10,…

2 hours ago

Spectral AI Names Vincent S. Capone as Chief Executive Officer

DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

2 hours ago